The chemical class known as GABAA Rγ1 inhibitors belongs to a group of compounds that exert their influence on a specific subtype of gamma-aminobutyric acid type A (GABAA) receptors, namely the γ1 subunit. GABAA receptors are integral components of the central nervous system, playing a crucial role in mediating inhibitory neurotransmission. The γ1 subunit, being a part of these receptors, is involved in modulating the receptor's functional properties and overall signaling. GABAA Rγ1 inhibitors interact with these receptors, affecting their activity by selectively targeting the γ1 subunit.
Through intricate molecular interactions, these inhibitors alter the receptor's conformation and subsequently impact its responsiveness to the neurotransmitter GABA (gamma-aminobutyric acid). This modulation of GABAA receptor function by targeting the γ1 subunit can have significant implications for neuronal communication and excitability, potentially leading to various physiological effects. The study of GABAA Rγ1 inhibitors provides insights into the complex mechanisms underlying neural signaling and opens avenues for exploring their role in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Flumazenil (Ro 15-1788) | 78755-81-4 | sc-200161 sc-200161A | 25 mg 100 mg | $110.00 $370.00 | 10 | |
Flumazenil is a competitive antagonist of the GABA(A) receptor, including the γ1 subunit. It is primarily used to reverse the effects of benzodiazepine overdose. | ||||||